JPRN-UMIN000047912
Completed
未知
Development of a novel deprescribing protocol focused on improving patient proactiveness - Development of a novel deprescribing protocol focused on improving patient proactiveness
ConditionsPolypharmacy
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Polypharmacy
- Sponsor
- St. Mariannna University School of Medicine
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Has a diagnosis of dementia 2\) Has a history of hospitalization with a change of prescription within 30 days 3\) Any other person deemed inappropriate by the principal investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of a patient oriented deprescribing strategy to achieve reduction of oversupply of proton pump inhibitors (PPI)medical counseling of patients regarding the reduction of oversupply of proton pump inhibitors (PPI)DRKS00016364Abteilung für Allgemeinmedizin, Präventive und Rehabilitative Medizin Philipps-Universität Marburg2,440
Completed
Not Applicable
Feasibility Study of a Systematic Approach for Deprescribing of Statins and PPI's.PolypharmacyNCT04204590Zuyderland Medisch Centrum75
Completed
Not Applicable
Deprescribing in Patients Living With Dementia With Caregiver and Provider NudgesAlzheimer DiseaseMild Cognitive ImpairmentDementiaNCT06347172Brigham and Women's Hospital250
Unknown
Not Applicable
Deprescribing of Symptomatic Medications in Rehabilitative or Subacute Care PatientsPolypharmacyAdverse Drug ReactionNCT03354845Bright Vision Hospital200
Completed
Not Applicable
Development and clinical testing of novel fixed dose combination of rifampicin and isoniazid treatment of tuberculosisHealth Condition 1: null- TuberculosisCTRI/2013/05/003626Department of Pharmaceuticals Ministry of Chemical Fertilizers100